pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker AQST. Primary therapeutic focus areas include Epilepsy, Allergic Reaction, Nausea and Vomiting, Postoperative
Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
DESF
Phase 2 · small molecule · Allergic Reaction
DESF for Allergic Reaction is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code AQ109206
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aquestive Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Allergic Reaction
- Status
- completed
- Trials
- 1